TB Alliance manages the largest pipeline of new TB drugs in history.
The Director of Preclinical Drug Evaluation will be a key member of the TB Alliance’s Research and Development team and responsible for managing programs in preclinical development. In addition, she/he will play a supporting role in advancing discovery and clinical programs. This position will report directly to the Chief Scientific Officer.
The Director will be responsible for helping to implement the research and pre-clinical development strategy of the TB Alliance. As a key member of the TB Alliance’s Research and Development team, the Director will:
TB Alliance is a not-for-profit organization dedicated to the discovery and development of better, faster, affordable tuberculosis drugs that are available to those who need them.Through innovative science and with partners around the globe, we lead a global effort to ensure development of and equitable access to faster, better tuberculosis cures that will advance global health and prosperity.
With an annual operating budget of approximately $60 million, the TB Alliance leads the advancement of the most comprehensive R&D portfolio of TB drug candidates in history. Additionally, the TB Alliance drives efforts to ensure regulatory approval, country adoption of new regimens, and widespread availability of new drug regimens to patients. For more information, please access the website: www.tballiance.org.